RESPONSE OF IGG SUBCLASSES TO DIETHYLCARBAMAZINE THERAPY IN BANCROFTIAN FILARIAL PATIENTS

Citation
Pk. Murthy et al., RESPONSE OF IGG SUBCLASSES TO DIETHYLCARBAMAZINE THERAPY IN BANCROFTIAN FILARIAL PATIENTS, Current Science, 72(4), 1997, pp. 265-268
Citations number
26
Categorie Soggetti
Multidisciplinary Sciences
Journal title
ISSN journal
00113891
Volume
72
Issue
4
Year of publication
1997
Pages
265 - 268
Database
ISI
SICI code
0011-3891(1997)72:4<265:ROISTD>2.0.ZU;2-7
Abstract
The response of IgG subclasses to diethylcarbamazine (DEC) treatment w as studied in bancroftian filariasis patients. On the basis of clinica l signs and parasitological examination, a total of 22 patients were c ategorized into asymptomatic microfilaraemics (AS-Mfmic; n = 12) and s ymptomatic amicrofilaraemics (S-AMfmic; n = 10). The subjects were tre ated with DEC (300 mg/day) for 21 days. Before treatment, AS-Mfmic cas es showed higher levels of IgG(1) and IgG(4) than the S-AMfmics wherea s IgG(2) was higher in S-AMfmics than in AS-Mfmics. DEC caused more th an 90% reduction in microfilaraemia by day 30 since the start of treat ment in AS-Mfmics, while S-AMfmics remained amicrofilaraemic throughou t the study period, In As-Mfmics, DEC treatment enhanced IgG(4) and de creased IgG(1) levels while IgG(2) and IgG(3) remained unaffected. In s-AMfmics, DEC treatment caused decrease in IgG(1), IgG(3) and IgG(4), while IgG(2) level remained unchanged, We report that DEC therapy bri ngs about changes in specific IgG(1) and IgG(4) in AS-Mfmics and IgG(1 ), IgG(3) and IgG(4) in S-AMfmics.